Immunomodulation and antitumor strategies targeting tumor microenvironment

Wu Xiaobo

doi:10.36922/mi.4359

Microbes & Immunity ›› 2025, Vol. 2 ›› Issue (1) : 1 -2. DOI: 10.36922/mi.4359

EDITORIAL

research-article

Immunomodulation and antitumor strategies targeting tumor microenvironment

Wu Xiaobo ^*

Author information +

History +

PDF (260KB)

Cite this article

Download citation ▾

Wu Xiaobo. Immunomodulation and antitumor strategies targeting tumor microenvironment. Microbes & Immunity, 2025, 2(1): 1-2 DOI:10.36922/mi.4359

登录浏览全文

4963

注册一个新账户忘记密码

Conflict of interest

Xiaobo Wu is the editorial board member of this journal and the guest editor of this special issue. The author declared that he has no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Rashid K, Ahmad A, Meerasa SS, et al. Cancer stem cell-derived exosome-induced metastatic cancer: An orchestra within the tumor microenvironment. Biochimie. 2023; 212: 1-11. doi: 10.1016/j.biochi.2023.03.014

[2]	Park J, Hsueh PC, Li Z, Ho PC. Microenvironment-driven metabolic adaptations guiding CD8⁺T cell anti-tumor immunity. Immunity. 2023; 56(1):32-42. doi: 10.1016/j.immuni.2022.12.008

[3]	Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023; 41(3):450-465. doi: 10.1016/j.ccell.2023.02.014

[4]	Zwergel C, Fioravanti R, Mai A. PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy? Drug Discov Today. 2023; 28(2):103435. doi: 10.1016/j.drudis.2022.103435